Michael Landsittel
2018
Compensation breakdown
| Non-Equity Incentive Plan | $92,278 |
|---|---|
| Option Awards | $1,358,404 |
| Salary | $281,678 |
| Other | $8,250 |
| Total | $1,740,610 |
Landsittel received $1.4M in option awards, accounting for 78% of the total pay in 2018.
Landsittel also received $92.3K in non-equity incentive plan, $281.7K in salary and $8.3K in other compensation.
Rankings
In 2018, Michael Landsittel's compensation ranked 6,426th out of 14,244 executives tracked by ExecPay. In other words, Landsittel earned more than 54.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,426 out of 14,244 | 55th |
Division Manufacturing | 2,457 out of 5,765 | 57th |
Major group Chemicals And Allied Products | 914 out of 2,128 | 57th |
Industry group Drugs | 768 out of 1,817 | 58th |
Industry Pharmaceutical Preparations | 596 out of 1,391 | 57th |
Pay ratio
| Michael Landsittel's Pay | $1,740,610 |
|---|---|
| Median Employee's Pay | $398,087 |
| Pay Ratio | 4to 1 |
In 2018, the annual total compensation of Michael Landsittel was $1,740,610.
The annual total compensation of the median employee at Blueprint Medicines was $398,087.
The ratio of Michael Landsittel's pay to the pay of median employee was therefore 4 to one.
Landsittel's colleagues
We found five more compensation records of executives who worked with Michael Landsittel at Blueprint Medicines in 2018.
2018
Jeffrey Albers
Blueprint Medicines
Chief Executive Officer
2018
Christina Rossi
Blueprint Medicines
Chief Commercial Officer
2018
Anthony Boral
Blueprint Medicines
Chief Medical Officer
2018
Tracey McCain
Blueprint Medicines
Chief Legal and Compliance Officer
2018
Kathryn Haviland
Blueprint Medicines